Technology

Prothena

$12.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.19 (-8.97%) Today
$0.00 (0.00%) As of 1:07 PM UTC after-hours

Why Robinhood?

You can buy or sell Prothena and other stocks, options, and ETFs commission-free!

About PRTA

Prothena Corporation plc Ordinary Shares, also called Prothena, is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland. The listed name for PRTA is Prothena Corporation plc Ordinary Shares.

CEO
Gene G. Kinney
Employees
51
Headquarters
Dun Laoghaire, Dublin
Founded
1969
Market Cap
500.38M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
190.94K
High Today
$13.50
Low Today
$11.88
Open Price
$12.97
Volume
338.36K
52 Week High
$14.72
52 Week Low
$7.10

Collections

PRTA Earnings

-$0.77
-$0.51
-$0.26
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 10, After Hours

You May Also Like

SNOA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure